Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

IRMD vs LNTH vs GEHC vs MDT vs ISRG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
IRMD
IRadimed Corporation

Medical - Devices

HealthcareNASDAQ • US
Market Cap$1.11B
5Y Perf.+206.6%
LNTH
Lantheus Holdings, Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • US
Market Cap$5.92B
5Y Perf.+78.6%
GEHC
GE HealthCare Technologies Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$27.90B
5Y Perf.+5.1%
MDT
Medtronic plc

Medical - Devices

HealthcareNYSE • IE
Market Cap$99.94B
5Y Perf.+0.3%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$161.07B
5Y Perf.+70.9%

IRMD vs LNTH vs GEHC vs MDT vs ISRG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
IRMD logoIRMD
LNTH logoLNTH
GEHC logoGEHC
MDT logoMDT
ISRG logoISRG
IndustryMedical - DevicesDrug Manufacturers - Specialty & GenericMedical - Healthcare Information ServicesMedical - DevicesMedical - Instruments & Supplies
Market Cap$1.11B$5.92B$27.90B$99.94B$161.07B
Revenue (TTM)$86M$1.55B$19.95B$35.48B$10.58B
Net Income (TTM)$24M$279M$1.50B$4.61B$2.98B
Gross Margin76.8%60.5%42.5%61.9%66.3%
Operating Margin32.4%18.8%12.5%17.9%30.5%
Forward P/E42.9x17.5x12.4x14.1x43.8x
Total Debt$0.00$738K$10.00B$28.52B$303M
Cash & Equiv.$51M$359M$4.51B$2.22B$3.37B

IRMD vs LNTH vs GEHC vs MDT vs ISRGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

IRMD
LNTH
GEHC
MDT
ISRG
StockDec 22May 26Return
IRadimed Corporation (IRMD)100306.6+206.6%
Lantheus Holdings, … (LNTH)100178.6+78.6%
GE HealthCare Techn… (GEHC)100105.1+5.1%
Medtronic plc (MDT)100100.3+0.3%
Intuitive Surgical,… (ISRG)100170.9+70.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: IRMD vs LNTH vs GEHC vs MDT vs ISRG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MDT leads in 3 of 7 categories (5-stock set), making it the strongest pick for capital preservation and lower volatility and dividend income and shareholder returns. IRadimed Corporation is the stronger pick specifically for valuation and capital efficiency and recent price momentum and sentiment. ISRG also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
IRMD
IRadimed Corporation
The Value Pick

IRMD is the #2 pick in this set and the best alternative if valuation efficiency is your priority.

  • PEG 0.58 vs MDT's 36.00
  • Lower P/E (42.9x vs 43.8x), PEG 0.58 vs 2.01
  • +72.4% vs ISRG's -15.4%
Best for: valuation efficiency
LNTH
Lantheus Holdings, Inc.
The Long-Run Compounder

LNTH is the clearest fit if your priority is long-term compounding and sleep-well-at-night.

  • 41.9% 10Y total return vs ISRG's 5.5%
  • Lower volatility, beta 0.47, Low D/E 0.1%, current ratio 2.70x
Best for: long-term compounding and sleep-well-at-night
GEHC
GE HealthCare Technologies Inc.
The Value Angle

Among these 5 stocks, GEHC doesn't own a clear edge in any measured category.

Best for: healthcare exposure
MDT
Medtronic plc
The Income Pick

MDT carries the broadest edge in this set and is the clearest fit for income & stability and defensive.

  • Dividend streak 36 yrs, beta 0.47, yield 3.6%
  • Beta 0.47, yield 3.6%, current ratio 1.85x
  • Beta 0.47 vs GEHC's 1.37, lower leverage
  • 3.6% yield, 36-year raise streak, vs IRMD's 1.3%, (2 stocks pay no dividend)
Best for: income & stability and defensive
ISRG
Intuitive Surgical, Inc.
The Growth Play

ISRG ranks third and is worth considering specifically for growth exposure.

  • Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
  • 20.5% revenue growth vs LNTH's 0.5%
  • 28.2% margin vs GEHC's 7.5%
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthISRG logoISRG20.5% revenue growth vs LNTH's 0.5%
ValueIRMD logoIRMDLower P/E (42.9x vs 43.8x), PEG 0.58 vs 2.01
Quality / MarginsISRG logoISRG28.2% margin vs GEHC's 7.5%
Stability / SafetyMDT logoMDTBeta 0.47 vs GEHC's 1.37, lower leverage
DividendsMDT logoMDT3.6% yield, 36-year raise streak, vs IRMD's 1.3%, (2 stocks pay no dividend)
Momentum (1Y)IRMD logoIRMD+72.4% vs ISRG's -15.4%
Efficiency (ROA)MDT logoMDT175.8% ROA vs GEHC's 4.1%, ROIC 6.0% vs 13.3%

IRMD vs LNTH vs GEHC vs MDT vs ISRG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

IRMDIRadimed Corporation
FY 2025
MRI Compatible Patient Vital Signs Monitoring Systems
100.0%$26M
LNTHLantheus Holdings, Inc.
FY 2025
Product
33.4%$1.5B
Radiopharmaceutical Oncology
21.9%$989M
PYLARIFY
21.9%$989M
Total Precision Diagnostics
10.9%$493M
DEFINITY
7.3%$330M
Techne Lite
1.9%$87M
Strategic Partnerships And Other
1.3%$59M
Other (2)
1.3%$59M
GEHCGE HealthCare Technologies Inc.
FY 2025
Imaging Segment
60.7%$9.2B
PCS Segment
20.3%$3.1B
PDx Segment
19.0%$2.9B
MDTMedtronic plc
FY 2025
Cardiac and Vascular Group
37.3%$12.5B
Neuroscience Group
29.4%$9.8B
Medical Surgical
25.1%$8.4B
Diabetes Group
8.2%$2.8B
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B

IRMD vs LNTH vs GEHC vs MDT vs ISRG — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLIRMDLAGGINGISRG

Income & Cash Flow (Last 12 Months)

IRMD leads this category, winning 3 of 6 comparable metrics.

MDT is the larger business by revenue, generating $35.5B annually — 411.3x IRMD's $86M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to GEHC's 7.5%. On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricIRMD logoIRMDIRadimed Corporat…LNTH logoLNTHLantheus Holdings…GEHC logoGEHCGE HealthCare Tec…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
RevenueTrailing 12 months$86M$1.5B$20.0B$35.5B$10.6B
EBITDAEarnings before interest/tax$30M$347M$3.3B$9.4B$3.8B
Net IncomeAfter-tax profit$24M$279M$1.5B$4.6B$3.0B
Free Cash FlowCash after capex$24M$372M$1.5B$5.4B$2.8B
Gross MarginGross profit ÷ Revenue+76.8%+60.5%+42.5%+61.9%+66.3%
Operating MarginEBIT ÷ Revenue+32.4%+18.8%+12.5%+17.9%+30.5%
Net MarginNet income ÷ Revenue+27.4%+18.0%+7.5%+13.0%+28.2%
FCF MarginFCF ÷ Revenue+27.9%+24.0%+7.6%+15.2%+26.8%
Rev. Growth (YoY)Latest quarter vs prior year+12.7%+1.2%+7.4%+8.8%+23.0%
EPS Growth (YoY)Latest quarter vs prior year+21.6%+76.5%-30.9%-11.9%+18.8%
IRMD leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

GEHC leads this category, winning 4 of 7 comparable metrics.

At 13.5x trailing earnings, GEHC trades at a 77% valuation discount to ISRG's 57.6x P/E. Adjusting for growth (PEG ratio), IRMD offers better value at 0.67x vs MDT's 36.00x — a lower PEG means you pay less per unit of expected earnings growth.

MetricIRMD logoIRMDIRadimed Corporat…LNTH logoLNTHLantheus Holdings…GEHC logoGEHCGE HealthCare Tec…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
Market CapShares × price$1.1B$5.9B$27.9B$99.9B$161.1B
Enterprise ValueMkt cap + debt − cash$1.1B$5.6B$33.4B$126.2B$158.0B
Trailing P/EPrice ÷ TTM EPS49.57x26.69x13.48x21.60x57.62x
Forward P/EPrice ÷ next-FY EPS est.42.94x17.52x12.40x14.13x43.84x
PEG RatioP/E ÷ EPS growth rate0.67x19.78x36.00x2.65x
EV / EBITDAEnterprise value multiple37.07x14.61x10.00x14.32x43.62x
Price / SalesMarket cap ÷ Revenue13.23x3.84x1.35x2.98x16.00x
Price / BookPrice ÷ Book value/share11.78x5.72x2.66x2.08x9.17x
Price / FCFMarket cap ÷ FCF64.53x16.73x18.53x19.28x64.67x
GEHC leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

IRMD leads this category, winning 4 of 9 comparable metrics.

IRMD delivers a 24.5% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $9 for MDT. LNTH carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to GEHC's 0.94x. On the Piotroski fundamental quality scale (0–9), MDT scores 6/9 vs GEHC's 4/9, reflecting solid financial health.

MetricIRMD logoIRMDIRadimed Corporat…LNTH logoLNTHLantheus Holdings…GEHC logoGEHCGE HealthCare Tec…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
ROE (TTM)Return on equity+24.5%+24.3%+14.4%+9.4%+16.9%
ROA (TTM)Return on assets+21.3%+12.4%+4.1%+175.8%+14.8%
ROICReturn on invested capital+50.2%+30.6%+13.3%+6.0%+15.0%
ROCEReturn on capital employed+27.8%+17.1%+10.8%+7.5%+16.5%
Piotroski ScoreFundamental quality 0–955466
Debt / EquityFinancial leverage0.00x0.94x0.59x0.02x
Net DebtTotal debt minus cash-$51M-$358M$5.5B$26.3B-$3.1B
Cash & Equiv.Liquid assets$51M$359M$4.5B$2.2B$3.4B
Total DebtShort + long-term debt$0$738,000$10.0B$28.5B$303M
Interest CoverageEBIT ÷ Interest expense11.72x5.35x9.08x
IRMD leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — IRMD and LNTH each lead in 3 of 6 comparable metrics.

A $10,000 investment in LNTH five years ago would be worth $41,420 today (with dividends reinvested), compared to $7,230 for MDT. Over the past 12 months, IRMD leads with a +72.4% total return vs ISRG's -15.4%. The 3-year compound annual growth rate (CAGR) favors IRMD at 23.3% vs GEHC's -8.0% — a key indicator of consistent wealth creation.

MetricIRMD logoIRMDIRadimed Corporat…LNTH logoLNTHLantheus Holdings…GEHC logoGEHCGE HealthCare Tec…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
YTD ReturnYear-to-date-9.0%+35.3%-25.9%-18.1%-19.3%
1-Year ReturnPast 12 months+72.4%+13.1%-10.7%-2.8%-15.4%
3-Year ReturnCumulative with dividends+87.6%-4.0%-22.2%-4.2%+49.6%
5-Year ReturnCumulative with dividends+214.1%+314.2%+2.9%-27.7%+58.7%
10-Year ReturnCumulative with dividends+433.9%+4192.5%+2.9%+26.5%+554.2%
CAGR (3Y)Annualised 3-year return+23.3%-1.4%-8.0%-1.4%+14.4%
Evenly matched — IRMD and LNTH each lead in 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — LNTH and MDT each lead in 1 of 2 comparable metrics.

MDT is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than GEHC's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LNTH currently trades 97.8% from its 52-week high vs GEHC's 68.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricIRMD logoIRMDIRadimed Corporat…LNTH logoLNTHLantheus Holdings…GEHC logoGEHCGE HealthCare Tec…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
Beta (5Y)Sensitivity to S&P 5000.85x0.47x1.37x0.47x1.02x
52-Week HighHighest price in past year$107.90$93.00$89.77$106.33$603.88
52-Week LowLowest price in past year$50.61$47.25$58.75$77.16$427.84
% of 52W HighCurrent price vs 52-week peak+80.4%+97.8%+68.3%+73.3%+75.1%
RSI (14)Momentum oscillator 0–10039.061.232.127.342.4
Avg Volume (50D)Average daily shares traded91K886K4.3M7.8M1.8M
Evenly matched — LNTH and MDT each lead in 1 of 2 comparable metrics.

Analyst Outlook

MDT leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: IRMD as "Buy", LNTH as "Buy", GEHC as "Buy", MDT as "Buy", ISRG as "Buy". Consensus price targets imply 40.5% upside for MDT (target: $110) vs 11.0% for LNTH (target: $101). For income investors, MDT offers the higher dividend yield at 3.57% vs GEHC's 0.23%.

MetricIRMD logoIRMDIRadimed Corporat…LNTH logoLNTHLantheus Holdings…GEHC logoGEHCGE HealthCare Tec…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyBuy
Price TargetConsensus 12-month target$120.00$101.00$84.00$109.50$622.60
# AnalystsCovering analysts217184955
Dividend YieldAnnual dividend ÷ price+1.3%+0.2%+3.6%
Dividend StreakConsecutive years of raises40336
Dividend / ShareAnnual DPS$1.17$0.14$2.78
Buyback YieldShare repurchases ÷ mkt cap0.0%+5.1%+0.7%+3.2%+1.4%
MDT leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

IRMD leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). GEHC leads in 1 (Valuation Metrics). 2 tied.

Best OverallIRadimed Corporation (IRMD)Leads 2 of 6 categories
Loading custom metrics...

IRMD vs LNTH vs GEHC vs MDT vs ISRG: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is IRMD or LNTH or GEHC or MDT or ISRG a better buy right now?

For growth investors, Intuitive Surgical, Inc.

(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus 0. 5% for Lantheus Holdings, Inc. (LNTH). GE HealthCare Technologies Inc. (GEHC) offers the better valuation at 13. 5x trailing P/E (12. 4x forward), making it the more compelling value choice. Analysts rate IRadimed Corporation (IRMD) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — IRMD or LNTH or GEHC or MDT or ISRG?

On trailing P/E, GE HealthCare Technologies Inc.

(GEHC) is the cheapest at 13. 5x versus Intuitive Surgical, Inc. at 57. 6x. On forward P/E, GE HealthCare Technologies Inc. is actually cheaper at 12. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: IRadimed Corporation wins at 0. 58x versus Medtronic plc's 36. 00x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — IRMD or LNTH or GEHC or MDT or ISRG?

Over the past 5 years, Lantheus Holdings, Inc.

(LNTH) delivered a total return of +314. 2%, compared to -27. 7% for Medtronic plc (MDT). Over 10 years, the gap is even starker: LNTH returned +41. 9% versus GEHC's +2. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — IRMD or LNTH or GEHC or MDT or ISRG?

By beta (market sensitivity over 5 years), Medtronic plc (MDT) is the lower-risk stock at 0.

47β versus GE HealthCare Technologies Inc. 's 1. 37β — meaning GEHC is approximately 193% more volatile than MDT relative to the S&P 500. On balance sheet safety, Lantheus Holdings, Inc. (LNTH) carries a lower debt/equity ratio of 0% versus 94% for GE HealthCare Technologies Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — IRMD or LNTH or GEHC or MDT or ISRG?

By revenue growth (latest reported year), Intuitive Surgical, Inc.

(ISRG) is pulling ahead at 20. 5% versus 0. 5% for Lantheus Holdings, Inc. (LNTH). On earnings-per-share growth, the picture is similar: Medtronic plc grew EPS 30. 8% year-over-year, compared to -21. 8% for Lantheus Holdings, Inc.. Over a 3-year CAGR, LNTH leads at 18. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — IRMD or LNTH or GEHC or MDT or ISRG?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus 10. 1% for GE HealthCare Technologies Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IRMD leads at 31. 2% versus 13. 4% for GEHC. At the gross margin level — before operating expenses — IRMD leads at 76. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is IRMD or LNTH or GEHC or MDT or ISRG more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, IRadimed Corporation (IRMD) is the more undervalued stock at a PEG of 0. 58x versus Medtronic plc's 36. 00x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, GE HealthCare Technologies Inc. (GEHC) trades at 12. 4x forward P/E versus 43. 8x for Intuitive Surgical, Inc. — 31. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MDT: 40. 5% to $109. 50.

08

Which pays a better dividend — IRMD or LNTH or GEHC or MDT or ISRG?

In this comparison, MDT (3.

6% yield), IRMD (1. 3% yield), GEHC (0. 2% yield) pay a dividend. LNTH, ISRG do not pay a meaningful dividend and should not be held primarily for income.

09

Is IRMD or LNTH or GEHC or MDT or ISRG better for a retirement portfolio?

For long-horizon retirement investors, Medtronic plc (MDT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

47), 3. 6% yield). Both have compounded well over 10 years (MDT: +26. 5%, GEHC: +2. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between IRMD and LNTH and GEHC and MDT and ISRG?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: IRMD is a small-cap quality compounder stock; LNTH is a small-cap quality compounder stock; GEHC is a mid-cap deep-value stock; MDT is a mid-cap income-oriented stock; ISRG is a mid-cap high-growth stock. IRMD, MDT pay a dividend while LNTH, GEHC, ISRG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

IRMD

Quality Mega-Cap Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Net Margin > 16%
Run This Screen
Stocks Like

LNTH

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 10%
Run This Screen
Stocks Like

GEHC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

MDT

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform IRMD and LNTH and GEHC and MDT and ISRG on the metrics below

Revenue Growth>
%
(IRMD: 12.7% · LNTH: 1.2%)
Net Margin>
%
(IRMD: 27.4% · LNTH: 18.0%)
P/E Ratio<
x
(IRMD: 49.6x · LNTH: 26.7x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.